149 related articles for article (PubMed ID: 20484992)
1. Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma.
Healey MA; Deaton SL; Alder JK; Winnepenninckx V; Casero RA; Herman JG
Epigenetics; 2010 Jul; 5(5):410-21. PubMed ID: 20484992
[TBL] [Abstract][Full Text] [Related]
2. Id1 expression is transcriptionally regulated in radial growth phase melanomas.
Ryu B; Kim DS; DeLuca AM; Healey MA; Dunlap S; Fackler MJ; Herman J; Alani RM
Int J Cancer; 2007 Oct; 121(8):1705-9. PubMed ID: 17565736
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
Polsky D; Young AZ; Busam KJ; Alani RM
Cancer Res; 2001 Aug; 61(16):6008-11. PubMed ID: 11507043
[TBL] [Abstract][Full Text] [Related]
4. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.
Asirvatham AJ; Carey JP; Chaudhary J
Prostate; 2007 Sep; 67(13):1411-20. PubMed ID: 17639499
[TBL] [Abstract][Full Text] [Related]
5. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
6. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
[TBL] [Abstract][Full Text] [Related]
8. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a.
Alani RM; Young AZ; Shifflett CB
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7812-6. PubMed ID: 11427735
[TBL] [Abstract][Full Text] [Related]
9. Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.
Sharma P; Patel D; Chaudhary J
Cancer Med; 2012 Oct; 1(2):187-97. PubMed ID: 23342268
[TBL] [Abstract][Full Text] [Related]
10. Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.
Lopes EC; Valls E; Figueroa ME; Mazur A; Meng FG; Chiosis G; Laird PW; Schreiber-Agus N; Greally JM; Prokhortchouk E; Melnick A
Cancer Res; 2008 Sep; 68(18):7258-63. PubMed ID: 18794111
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1, Id1 and EMT in breast cancer.
Tobin NP; Sims AH; Lundgren KL; Lehn S; Landberg G
BMC Cancer; 2011 Sep; 11():417. PubMed ID: 21955753
[TBL] [Abstract][Full Text] [Related]
12. Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.
Qian T; Lee JY; Park JH; Kim HJ; Kong G
Oncogene; 2010 Oct; 29(43):5818-27. PubMed ID: 20697353
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.
Witcher M; Emerson BM
Mol Cell; 2009 May; 34(3):271-84. PubMed ID: 19450526
[TBL] [Abstract][Full Text] [Related]
15. TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
Peres J; Damerell V; Chauhan J; Popovic A; Desprez PY; Galibert MD; Goding CR; Prince S
J Invest Dermatol; 2021 Sep; 141(9):2250-2260.e2. PubMed ID: 33744299
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of differentiation 1 (ID1) promotes cell survival and proliferation of prostate epithelial cells.
Schmidt M; Asirvatham AJ; Chaudhary J
Cell Mol Biol Lett; 2010 Jun; 15(2):272-95. PubMed ID: 20186495
[TBL] [Abstract][Full Text] [Related]
17. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
Nagasawa T; Zhang Q; Raghunath PN; Wong HY; El-Salem M; Szallasi A; Marzec M; Gimotty P; Rook AH; Vonderheid EC; Odum N; Wasik MA
Leuk Res; 2006 Mar; 30(3):303-12. PubMed ID: 16185764
[TBL] [Abstract][Full Text] [Related]
18. Frequent p16-independent inactivation of p14ARF in human melanoma.
Freedberg DE; Rigas SH; Russak J; Gai W; Kaplow M; Osman I; Turner F; Randerson-Moor JA; Houghton A; Busam K; Timothy Bishop D; Bastian BC; Newton-Bishop JA; Polsky D
J Natl Cancer Inst; 2008 Jun; 100(11):784-95. PubMed ID: 18505964
[TBL] [Abstract][Full Text] [Related]
19. ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.
Geng H; Rademacher BL; Pittsenbarger J; Huang CY; Harvey CT; Lafortune MC; Myrthue A; Garzotto M; Nelson PS; Beer TM; Qian DZ
Cancer Res; 2010 Apr; 70(8):3239-48. PubMed ID: 20388787
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of Id1 and p16 proteins in all-trans-retinoic acid-induced apoptosis and cell cycle re-distribution in melanoma.
Zhang H; Rosdahl I
Cancer Lett; 2005 Jan; 217(1):33-41. PubMed ID: 15596294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
